Hanson M
Memorial Blood Centers of Minnesota, Minneapolis, USA.
Clin Lab Med. 1996 Dec;16(4):883-93.
A decision model was developed to evaluate the costs and benefits of further reducing the risk of transfusion-transmitted disease. The model addresses recipient risk factors as well as operational considerations. Application of the model to prior risk reduction decisions documents its validity as a decision-making tool. Adoption of such a standardized decision-making approach would ensure recipient safety while controlling the costs of providing blood for transfusion.
开发了一种决策模型，以评估进一步降低输血传播疾病风险的成本和收益。该模型考虑了受血者的风险因素以及操作方面的因素。将该模型应用于先前的风险降低决策证明了其作为决策工具的有效性。采用这种标准化的决策方法将确保受血者安全，同时控制输血用血的成本。
